Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder

NCT02273154 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Major Depression Disorder

Interventions

DRUG: Buspirone
DRUG: Paroxetine

Sponsor

Si Tianmei